Enhabit, Inc. $EHAB Stock Position Decreased by Paradice Investment Management LLC

Paradice Investment Management LLC trimmed its stake in Enhabit, Inc. (NYSE:EHAB) by 5.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,643,889 shares of the company’s stock after selling 93,075 shares during the period. Enhabit makes up approximately 3.0% of Paradice Investment Management LLC’s holdings, making the stock its 16th biggest position. Paradice Investment Management LLC’s holdings in Enhabit were worth $15,157,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of EHAB. Hennion & Walsh Asset Management Inc. purchased a new stake in shares of Enhabit during the fourth quarter valued at $142,000. SG Americas Securities LLC acquired a new position in shares of Enhabit during the 4th quarter worth $180,000. Verition Fund Management LLC bought a new position in shares of Enhabit during the 3rd quarter valued at $228,000. Mercer Global Advisors Inc. ADV acquired a new stake in shares of Enhabit in the 3rd quarter valued at $95,000. Finally, Bank of America Corp DE lifted its stake in shares of Enhabit by 73.3% in the 3rd quarter. Bank of America Corp DE now owns 687,934 shares of the company’s stock valued at $5,510,000 after purchasing an additional 290,978 shares during the last quarter.

Insider Transactions at Enhabit

In other Enhabit news, EVP Julie Diane Jolley sold 2,793 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $13.63, for a total value of $38,068.59. Following the sale, the executive vice president owned 139,923 shares of the company’s stock, valued at $1,907,150.49. This trade represents a 1.96% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 3.40% of the stock is owned by company insiders.

Enhabit Stock Performance

NYSE:EHAB opened at $13.74 on Friday. The firm has a market capitalization of $703.64 million, a PE ratio of -152.61 and a beta of 1.45. Enhabit, Inc. has a 1 year low of $6.47 and a 1 year high of $14.22. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.76. The firm’s fifty day simple moving average is $13.42 and its 200 day simple moving average is $10.74.

Enhabit (NYSE:EHAB) last released its earnings results on Thursday, March 5th. The company reported $0.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.14. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. The firm had revenue of $270.40 million during the quarter, compared to analyst estimates of $270.56 million. On average, sell-side analysts anticipate that Enhabit, Inc. will post 0.54 EPS for the current year.

Analyst Ratings Changes

Several research firms have commented on EHAB. UBS Group reissued a “neutral” rating and set a $13.80 target price (up from $12.00) on shares of Enhabit in a research report on Tuesday, February 24th. Oppenheimer downgraded Enhabit from an “outperform” rating to a “market perform” rating in a research note on Monday, February 23rd. Truist Financial set a $13.80 price objective on Enhabit in a report on Monday, February 23rd. Wolfe Research set a $12.00 price objective on Enhabit in a research note on Thursday, January 8th. Finally, TD Cowen restated a “hold” rating and issued a $13.80 target price (up from $12.00) on shares of Enhabit in a report on Friday, March 6th. Two equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $13.57.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.